Hypopituitarism secondary prevention
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Iqra Qamar M.D.[2] , Ahmed Elsaiey, MBBCH [3]
Overview
Secondary prevention may be done by long term monitoring of patients for complications of hormonal replacement therapy and by dose adjustments in stressful situations.
Secondary Prevention
- Secondary prevention may be done by long term monitoring of patients:
- For complications of hormonal replacement therapy (under-replacement/over replacement)[1]
- By adjusting the dosages in stressful situations
References
- ↑ Harsch IA, Schuller A, Hahn EG, Hensen J (2010). “Cortisone replacement therapy in endocrine disorders – quality of self-care”. J Eval Clin Pract. 16 (3): 492–8. doi:10.1111/j.1365-2753.2009.01149.x. PMID 20210825.
© 2026 MyEClinic – IFTM Institut für Telematik in der Medizin GmbH